ALEXION PHARDRN (Brazil) Valuation

Do you wonder what the value of ALEXION PHARDRN is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as ALEXION PHARDRN, is its stock price multiplied by the total number of shares outstanding, calculating ALEXION PHARDRN's enterprise value requires a different approach. It uses ALEXION PHARDRN's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
ALEXION PHARDRN prevailing Real Value cannot be determined due to lack of data. The current price of ALEXION PHARDRN is R$0.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Our model approximates the value of ALEXION PHARDRN from examining the firm fundamentals such as Profit Margin of 10.89 %, return on equity of 4.43 %, and Current Valuation of 196.31 B as well as evaluating its technical indicators and Probability Of Bankruptcy. In general, we favor taking in undervalued instruments and trading overvalued instruments since, in the future, asset prices and their ongoing real values will blend.
ALEXION PHARDRN Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as ALEXION PHARDRN's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

ALEXION PHARDRN Total Value Analysis

ALEXION PHARDRN is presently forecasted to have takeover price of 196.31 B with market capitalization of 200.24 B, debt of 2.88 B, and cash on hands of 3.47 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ALEXION PHARDRN fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
196.31 B200.24 B2.88 B3.47 B

ALEXION PHARDRN Investor Information

The company recorded earning per share (EPS) of 7.64. ALEXION PHARDRN had not issued any dividends in recent years. Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company was founded in 1992 and is headquartered in Boston, Massachusetts. ALEXION PHARDRN operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 3837 people. For more info on ALEXION PHARDRN please contact the company at 475 230 2596 or go to

ALEXION PHARDRN Asset Utilization

One of the ways to look at asset utilization of ALEXION is to check how much profit was generated for every dollar of assets it reports. ALEXION PHARDRN utilizes its assets nearly 10.08 percent, attaining R$0.1 for each real of assets held by the firm. A positive asset utilization signifies that the company is slightly more productive with each real of assets it shows. Put another way, asset utilization of ALEXION PHARDRN shows how productive it operates for each real spent on its assets.

ALEXION PHARDRN Ownership Allocation (%)

ALEXION PHARDRN retains a total of 442.04 Million outstanding shares. Almost 100.0 percent of ALEXION PHARDRN outstanding shares are held by regular investors with 0.0 (percent) owned by insiders and only 0.03 % by other corporate entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
   Ownership %   

ALEXION PHARDRN Profitability Analysis

The company reported the revenue of 6.26 B. Net Income was 681.8 M with profit before overhead, payroll, taxes, and interest of 5.52 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ALEXION PHARDRN's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ALEXION PHARDRN and how it compares across the competition.
Check out Trending Equities. Note that the ALEXION PHARDRN information on this page should be used as a complementary analysis to other ALEXION PHARDRN's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Tools for ALEXION Stock

When running ALEXION PHARDRN price analysis, check to measure ALEXION PHARDRN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALEXION PHARDRN is operating at the current time. Most of ALEXION PHARDRN's value examination focuses on studying past and present price action to predict the probability of ALEXION PHARDRN's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ALEXION PHARDRN's price. Additionally, you may evaluate how the addition of ALEXION PHARDRN to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings